Hunan Nucien Pharmaceutical Co. Ltd.SSE: 688189

Notice on Convening the 2nd Extraordinary General Meeting in 2025

· Issued by Hunan Nucien Pharmaceutical Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · · 8 pages · Chinese

Summary by 6ix AI

Key agenda items include the proposal to change the accounting firm and the election of non-independent directors for the second board. Shareholders must register to attend the meeting and can delegate their voting rights to a representative if necessary.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Notice on Convening the 2nd Extraordinary General Meeting in 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Hunan Nucien Pharmaceutical Co. Ltd. on 6ix

Earlier from Hunan Nucien Pharmaceutical

Later from Hunan Nucien Pharmaceutical

All Hunan Nucien Pharmaceutical news releases